Synaptys Neuroscience: preventing Alzheimer’s disease with combination therapy
… positive results in vitro in a study carried out in 2022: according to Sébastien Lasnier, “42 per cent of … candidate, the start-up went through four stages. The first was to identify the right molecules, which took two years. … initial discussions with pharmaceutical companies in order to carry out the final trials required and bring our …
Published on: